Recruiting Alzheimers Disease Studies in Fargo
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
This multicenter, open-label, randomized phase 3 trial will determine if palbociclib and cetuximab (Arm 1) improves overall survival (OS) in comparison to cetuximab monotherapy (Arm 2) in patients wit...
An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)
This is a study to evaluate the pharmacokinetic (PK) and safety of sonelokimab in adolescent patients with HS....
About Alzheimers Disease Clinical Trials in Fargo
Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.
There are currently 2 alzheimers disease clinical trials recruiting participants in Fargo, NORTH%20DAKOTA. These studies are seeking a combined 116 participants. Research is being sponsored by Washington University School of Medicine, MoonLake Immunotherapeutics AG. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alzheimers Disease Clinical Trials in Fargo — FAQ
Are there alzheimers disease clinical trials in Fargo?
Yes, there are 2 alzheimers disease clinical trials currently recruiting in Fargo, NORTH%20DAKOTA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fargo?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fargo research site will contact you about next steps.
Are clinical trials in Fargo free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fargo studies also compensate for your time and travel.
What alzheimers disease treatments are being tested?
The 2 active trials in Fargo are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.
Data updated March 2, 2026 from ClinicalTrials.gov